University of Sussex
Browse
Validity of Biomarkers of Early.pdf (232.83 kB)
Download file

Validity of biomarkers of early circulatory impairment to predict outcome: a retrospective analysis

Download (232.83 kB)
journal contribution
posted on 2023-06-09, 17:57 authored by MaríaCarmen Bravo, Paloma López-Ortego, Laura Sánchez, Rosario Madero, Fernando Cabañas, Armin Koch, Héctor Rojas-Anaya, Heike RabeHeike Rabe, Adelina Pellicer, on behalf of NeoCirculation Consortium (NEO-CIRC)
Objectives: The definition of circulatory impairment in the premature infant is controversial. Current research suggests overdiagnosis and overtreatment. We aimed to analyse which biomarkers move clinicians to initiate cardiovascular treatment (CVT). The prognostic capacity for adverse outcome (death and/or moderate-severe brain damage by cranial ultrasound at term equivalent) of these biomarkers was evaluated. Study Design: Retrospective data analysis from preterm infants enrolled in a placebo-controlled trial on dobutamine for low superior vena cava (SVC) flow, who showed normal SVC flow within the first 24 h (not randomized). Five positive biomarkers were considered: MABP < gestational age (GA)-1 mmHg; MABP < GA-5 mmHg; lactate > 4 mmol/L; BE < -9 mmol/L; SVC flow <51 ml/kg/min. Results: Ninety eight infants formed the study cohort. Thirty six received CVT (2–95 h). Logistic regression models adjusted for gestational age showed a positive association between CVT and the risk of death or moderate-severe abnormal cranial ultrasound at term equivalent [(OR 5.2, 95%CI: 1.8–15.1) p = 0.002]. MABP < GA-1 mmHg and lactate > 4 mmol/L were the most prevalent biomarkers at start of treatment. Low BE, high serum lactate and low SVC flow at first echocardiography showed a trend toward being associated with adverse outcome, although not statistically significant. Conclusions: Low blood pressure and high lactate are the most prevalent biomarkers used for CVT prescription. Lactic acidosis and low SVC flow early after birth showed a trend toward being associated with adverse outcome. These findings support using a combination of biomarkers for inclusion in a placebo-controlled trial on CVT during transitional circulation.

History

Publication status

  • Published

File Version

  • Published version

Journal

Frontiers in Pediatrics

ISSN

2296-2360

Publisher

Frontiers Media

Issue

212

Volume

7

Page range

1-8

Department affiliated with

  • BSMS Publications

Full text available

  • Yes

Peer reviewed?

  • Yes

Legacy Posted Date

2019-05-31

First Open Access (FOA) Date

2019-05-31

First Compliant Deposit (FCD) Date

2019-05-31

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Licence

    Exports